Clinical Trials Directory

Trials / Completed

CompletedNCT07229469

A Study on Sumac Mouth Rinse for Treating Recurrent Aphthous Stomatitis

Sumac Mouth Rinse in the Management of Recurrent Aphthous Stomatitis (A Randomized Controlled Clinical Study With Biochemical Assessment)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

This randomized controlled clinical study aims to evaluate the effectiveness of a Sumac mouth rinse in the management of recurrent aphthous stomatitis (RAS). In addition to assessing clinical improvement in ulcer healing and pain reduction, biochemical analysis will be performed by measuring serum TNF-α levels to evaluate the anti-inflammatory effect of Sumac.

Detailed description

Recurrent aphthous stomatitis (RAS) is one of the most common oral mucosal disorders, characterized by recurrent, painful ulcers that interfere with eating and speaking. The etiology of RAS is multifactorial and involves immune dysregulation and increased levels of inflammatory cytokines, particularly tumor necrosis factor-alpha (TNF-α). Sumac (Rhus coriaria) is a natural herbal extract known for its anti-inflammatory, antioxidant, and antimicrobial properties. This randomized controlled clinical study aims to evaluate the clinical effectiveness of a Sumac mouth rinse in promoting ulcer healing and reducing pain among patients with recurrent aphthous stomatitis. In addition to clinical assessment, biochemical evaluation of serum TNF-α levels will be performed before and after treatment to investigate the possible anti-inflammatory mechanism of Sumac. The study findings are expected to provide new insights into the potential therapeutic role of Sumac in managing RAS.

Conditions

Interventions

TypeNameDescription
OTHERSumac mouth rinseHerbal mouth rinse containing Sumac extract
DRUGTantum Verde mouth rinseStandard mouth rinse according to manufacturer instructions

Timeline

Start date
2023-12-20
Primary completion
2025-05-25
Completion
2025-08-18
First posted
2025-11-17
Last updated
2025-11-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07229469. Inclusion in this directory is not an endorsement.